Ajanta Pharma USA Inc Aripiprazole Tablets USP recall: Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
The hazard: Drug safety concern
This is an FDA enforcement action. The summary above is the agency’s own description of what went wrong.
What the notice says: Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Why it matters: The FDA recorded an enforcement action against this product. The classification and the summary above describe how serious the agency considers it.
Recall details
- Recall number
- D-0594-2026
- Published
- June 24, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Ajanta Pharma USA Inc
- Product type
- Prescription & OTC drugs
- Units affected
- 6,143 bottles
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot: PA00805, expires: 01/31/2029
Products covered by this recall
Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.
Check your product
The notice names 7 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- PA00805
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 01
- 31
- 2029 — 6
- 143 bottles
NDC number
On the carton and again on the bottle or blister label.
- 27241-056-03
Package size
Match the net weight or the piece count on the front of the pack.
- 30 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Drug safety
Ajanta Pharma USA Inc — This is an FDA enforcement action. The summary above is the agency’s own description of what went wrong.
- Check the lot number on your pack against the codes listed above.
- Do not stop a prescribed medicine on your own — speak to your prescriber or pharmacist first.
- Ask the dispensing pharmacy for a replacement from an unaffected lot.
- Keep the carton; the lot number is often printed only on the outer pack.
Refunds and replacements
With medicines, a replacement supply matters more than cash, and that is what pharmacies are set up to provide.
- Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
- For a mail-order or online pharmacy, use the recall line listed on this page rather than the general support queue.
- If the recall voided a fill you had already paid for, your insurer will normally authorise a replacement ahead of schedule. Quote the recall number.
- If you paid out of pocket, ask for a refund of the co-pay or purchase price and keep the receipt the pharmacy issues.
Company contact: Ajanta Pharma USA Inc — 400 Crossing Blvd Ste 102, Bridgewater, NJ, 08807-2863
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Ajanta Pharma USA Inc prescription & otc drugs recalled?
Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code PA00805; best-by date 01 or 31. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above.
Can I get my money back?
Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 18 days ago
Ajanta Pharma USA Inc Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle recall: Failed Dissolution Specifications: below specification
Failed Dissolution Specifications: below specification
-
Class III · last month
Ajanta Pharma USA Inc Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles recall: Failed impurities/degradation specifications: (OOS) for Organic Impurities
Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability…
-
Class II · 4 months ago
Ajanta Pharma USA Inc Fenofibrate Capsules, USP 200 mg recall: CGMP Deviations
CGMP Deviations
-
Class II · 6 months ago
Ajanta Pharma Ltd. Duloxetine Delayed-Release Capsules, 30 mg recall: CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term…
-
Class II · 6 months ago
Ajanta Pharma Ltd. Duloxetine Delayed-Release Capsules, 20 mg recall: CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term…
-
Class II · 6 months ago
Ajanta Pharma Ltd. Duloxetine Delayed-Release Capsules, 60 mg recall: CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term…